Maximus vs MyStart: Compare GLP-1 Programs & Pricing
Side-by-side Maximus and MyStart: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
Maximus and MyStart are two telehealth companies providing access to GLP-1–class therapies for weight-management under clinician supervision. This comparison focuses on transparent pricing signals, membership requirements, clinical process, and safety considerations so you can decide which one aligns with your needs.
Maximus vs MyStart: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| Maximus | — | $132.99 | — | No |
| MyStart | $179.00 | $299.00 | Code: EXPLORE2026 | Varies |
The table above shows starting prices where available. Note that telehealth pricing can vary by dose, supply size, and whether the medication is compounded or an FDA-approved branded formulation. Always confirm current pricing at checkout.
Maximus vs MyStart: Medical Process & Accessibility
Both providers operate via telehealth: you complete an intake, submit health history, and are evaluated by a licensed clinician who determines medical appropriateness. If approved, prescriptions are coordinated with U.S.-based pharmacies and shipped to your address. These services require an initial medical evaluation — prescriptions for GLP-1 medications are prescription-only and only dispensed after clinician review.
Maximus emphasizes fast intake and streamlined approvals for patients who meet eligibility criteria, while MyStart highlights structured follow-up and dose adjustments with clinician contact. Neither platform replaces in-person emergency care; both advise contacting local medical services for urgent concerns.
Maximus vs MyStart: Pricing Comparison
For transparent comparison: Maximus lists tirzepatide from $132.99, while MyStart lists tirzepatide from $299.00. For semaglutide, MyStart lists a starting price of $179.00; Maximus does not display a public semaglutide starting price in the provided data. In this direct pairing the lower tirzepatide price is Maximus at $132.99, and the available semaglutide listing is MyStart at $179.00.
Prices may reflect a specific supply (for example, a monthly supply or a particular formulation) and do not include clinician consultation fees, shipping, or optional membership add-ons. MyStart currently advertises promo code EXPLORE2026 which can reduce first-order costs; confirm promo applicability and terms on the provider site.
Maximus vs MyStart: Clinical Oversight & Support
Both platforms connect patients with licensed clinicians who assess medical history, medications, and contraindications before prescribing. Telehealth clinicians follow standard safety protocols: screening for pregnancy, pancreatitis history, severe gastrointestinal disease, or other contraindications that would make GLP-1 therapy inappropriate.
Book a Consultation with Maximus
Follow-up care frequency varies. MyStart notes ongoing dose adjustments as part of its model, whereas Maximus is positioned toward a faster onboarding experience with clinician follow-ups as clinically indicated. Expect to report side effects and weight loss progress so clinicians can tailor dosing.
Maximus vs MyStart: Medication Quality & Safety
Some telehealth vendors prescribe branded, FDA-approved GLP-1 medications when available; others coordinate compounded formulations through licensed pharmacies. Compounded versions are legally prescribed under clinician supervision but are not identical to branded formulations and are not FDA-approved brand products. Discuss formulation, sourcing, and storage instructions with your clinician prior to starting therapy.
Verify Maximus Pharmacy Partners
Maximus vs MyStart: Customer Experience
User reports typically highlight Maximus for competitive tirzepatide pricing and quick processing, while MyStart receives positive feedback for patient communication and structured follow-up. Shipping windows commonly range from several days to about a week after approval, but can vary by pharmacy and location.
Maximus vs MyStart: Final Verdict
Choose Maximus if initial tirzepatide price and fast onboarding are top priorities. Choose MyStart if you prefer a provider that emphasizes structured follow-up and clear promo options (use code EXPLORE2026 where applicable). Both are telehealth pathways to clinician-prescribed GLP-1 therapy; select the one whose clinical approach and cost structure match your expectations and medical needs.
Join Maximus
Get Started with MyStart
Disclaimer
This article is for informational purposes only and does not constitute medical advice. Treatments discussed are prescription-only and require clinician evaluation. Prices and promotions can change; always confirm details directly with the provider. Consult a licensed clinician before beginning any medication. ExploreProviders/GLP1Talks may receive affiliate compensation for links shown at no extra cost to you.